Trial Profile
A Phase 1 Dose-escalation Study TO Evaluate the Safety and Tolerability of PUR118 and Placebo in Subjects With CF
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 06 Nov 2021
Price :
$35
*
At a glance
- Drugs PUR 118 (Primary)
- Indications Cystic fibrosis
- Focus Adverse reactions
- Sponsors Pulmatrix
- 31 Oct 2014 New trial record